Oaktree Specialty Lending issues $300M 7.100% Notes due 2029 to reduce credit facility debt

Oaktree Specialty Lending Corp

Issued $300 million principal amount of 7.100% Notes due February 15, 2029.
Net proceeds to reduce outstanding debt under revolving credit facilities and for general corporate purposes.
Notes are direct unsecured senior obligations; interest payable semiannually starting February 15, 2024.
Offering closed on August 15, 2023; priced via preliminary and final prospectus supplements dated August 8, 2023.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.9

Oaktree Specialty Lending Corp entered into Seventh Supplemental Indenture with Deutsche Bank Trust Company Americas valued at $300 million aggregate principal amount of its 7.100% Notes due 2029 (effective 2023-08-15).

Action: entry
Agreement: notes offering
Counterparty: Deutsche Bank Trust Company Americas
Value: $300 million aggregate principal amount of its 7.100% Notes due 2029
Effective: 2023-08-15

Exact text from the filing

On August 15, 2023, in connection with a previously announced public offering, Oaktree Specialty Lending Corporation (the “Company”) and Deutsche Bank Trust Company Americas, as trustee (the “Trustee”), entered into a Seventh Supplemental Indenture (the “Seventh Supplemental Indenture”) to the Indenture, dated April 30, 2012, between the Company and the Trustee (the “Indenture”). The Seventh Supplemental Indenture relates to the Company’s issuance, offer and sale of $ 300 million aggregate principal amount of its 7.100 % Notes due 2029 (the “Notes”).

View on SEC.gov

Browse all material agreements →

Oaktree Specialty Lending Corp filing history →

Source: SEC EDGAR

accession 0001193125-23-213457

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.